The Covid-19 pandemic has caught most countries’ healthcare systems off-guard and skyrocketed demand for products such as ventilators and medicines. It has reached such a point that countries are outbidding one another to secure their own supplies — a competition that is highly detrimental to nations with less economic firepower.
Brazil’s pharmaceutical industry has encountered problems procuring at least 31 tons of inputs used to produce 23 medicines — including some that are being tested against Covid-19, such as chloroquine, which hospitals are administering to patients in severe conditions. These supplies have been halted by the Indian government, a move that has grown common as countries worry that allowing massive international sales might leave them exposed to shortages.
Personal protective equipment (PPE) is also running low in many hospitals, as we informed in our April 2 Daily Briefing (for premium subscribers only). Health Minister Luiz Henrique Mandetta has said Brazil’s attempts to procure PPE and respirators from China have come up empty, after the U.S. made massive purchases from the same suppliers. “They say there’s no stock left,” Mr. Mandetta told reporters.
The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…
Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…
The preliminary report on AI regulations presented to Brazil’s Senate last week provides a middle-of-the-road…
In 2000, Formula 1 great Michael Schumacher had just racked up his 41st race win,…
Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…